Publication performance: German epidemiologists are strongly represented!

German epidemiology plays a remarkably strong role compared to other medical disciplines in terms of citation metrics

© Helmholtz Munich

Until now, a more detailed analysis of publication activities and citations in German epidemiology was hardly possible because the data required for this and, above all, the assignment of authors to the subject "epidemiology" were not available. In the Stanford list of the 2% most cited scientists published in 2020, individual data on publication activities and citation indicators are made available for the first time. These were evaluated for epidemiologists working in Germany.

Prof. Dr. Dr. H.-E. Wichmann concludes after a careful review of the "Stanford List" that German epidemiology plays a remarkably strong role in terms of citations compared to other medical disciplines. According to his count and definition, a total of 54 epidemiologists working in Germany can be found on this compilation of approx. 150,000 authors worldwide.

A very pleasant fact is that many of our institute's staff members are listed by name among the most frequently cited authors!

Wichmann HE. Publikationsaktivität und Zitationshäufigkeit der in Deutschland tätigen Epidemiologen. GMS Med Inform Biom Epidemiol. 2021;17(3):Doc13. DOI: 10.3205/mibe000227 


Editorial from Prof. Dr. Timmer

As German Research Center for Environmental Health, Helmholtz Munich pursues the goal of developing personalized medical approaches for the prevention and therapy of major common diseases such as diabetes mellitus, allergies and lung diseases. To achieve this, it investigates the interaction of genetics, environmental factors and lifestyle. The Helmholtz Zentrum München has about 2,300 staff members and is headquartered in Neuherberg in the north of Munich. Helmholtz Zentrum München is a member of the Helmholtz Association, a community of 19 scientific-technical and medical-biological research centers with a total of about 37,000 staff members. 

The Institute of Epidemiology (EPI) assesses genetic, environmental and lifestyle risk factors which jointly determine the occurrence of major chronic diseases. The focus is on the development and progression of metabolic, respiratory and allergic diseases, as well as heart diseases and mental health. The goal is to understand the molecular underpinning of disease better and to translate this knowledge into personalized approaches of prevention as well as polices to improve health. Research builds on the unique resources of the KORA cohort, the KORA myocardial infarction registry, and the KORA aerosol measurement station. Aging-related phenotypes have been added to the KORA research portfolio within the frame of the Research Consortium KORA-Age. Moreover, the institute makes use of the birth cohorts GINI and LISA. It plays a leading role in the planning and setting up of the German National Cohort and builds the NAKO biorepository.